Flux Analyzer Plate

Oxygen consumption serves as an estimate of mitochondrial respiration, whereas extracellular acidification indicates glycolytic activity. Examining both signals helps distinguish how cells generate energy rather than relying on a single metabolic measurement. In cancer research, this paired view supports comparisons between metabolic phenotypes and reveals whether differences are associated more strongly with respiration, glycolysis, or both.

Sequential additions perturb cellular metabolism in a controlled order. Inhibitors can reveal how strongly cells depend on particular metabolic processes, while substrates can test responses to altered fuel availability. Comparing measurements before and after each addition helps researchers evaluate pathway-related changes and determine how cancer cells adjust their energy metabolism under defined assay conditions.

Changes in oxygen consumption or extracellular acidification can indicate distinct metabolic phenotypes among cell populations. They may also show whether tumor cells alter mitochondrial respiration or glycolytic activity when exposed to drugs or different nutrient conditions. These patterns provide a functional basis for comparing cancer cells with nonmalignant cells and for studying metabolic adaptation.

Cells are placed in individual wells of the plate, allowing measurements from separate experimental samples or conditions. The plate is used with an extracellular flux analyzer, which tracks changes in oxygen consumption and extracellular acidification during the assay. Sequential additions of selected inhibitors or substrates then provide measurements for evaluating metabolic responses over the experiment.

This approach is useful when researchers need to compare how tumor cells and nonmalignant cells obtain energy or respond to metabolic challenges. It can support studies of drug effects, nutrient-dependent adaptation, and differences between cellular metabolic phenotypes. The resulting measurements help connect treatment or culture conditions with changes in mitochondrial respiration and glycolytic activity.

Researchers can measure cellular energy metabolism before and after sequential exposure to metabolic inhibitors or substrates, while also examining drug-related changes when the assay is designed for treatment comparisons. Altered oxygen consumption or extracellular acidification can indicate a shift in respiration or glycolysis. This supports evaluation of whether tumor cells retain, reduce, or adapt their metabolic activity under treatment conditions.